Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Burley

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|March 11, 1972
Supplementary potassiumD M Burley
Lancet (London, England)|August 18, 1979
Identifying the medical consultants of pharmaceutical companiesD M Burley
Journal of Clinical and Hospital Pharmacy|March 1, 1982
Therapeutic progress--Review III. Can drugs prevent recurrent myocardial infarction?D M Burley
Lancet (London, England)|April 2, 1983
Butter advertisingD M Burley
Lancet (London, England)|April 5, 1986
Should a drug company employee edit a medical journal?D M Burley
Lancet (London, England)|May 1, 1971
Halogenated oxyquinoline derivativesD M Burley
Postgraduate Medical Journal|July 1, 1970
Aminoglutethimide: a "side-effect" turned to therapeutic advantageS W Hughss, D M Burley
Lancet (London, England)|May 29, 1976
Letter: Erroneous adverse reaction reportsD M Burley, T B Binns
Medecine & Chirurgie Digestives|May 8, 1976
Rifampicine and enzyme inductionM Davies, R Williams, D M Burley
British Medical Journal|January 15, 1972
Effect of rifampicin and isoniazid on liver functionS Lal, S N Singhal, D M Burley, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|March 11, 1972
Supplementary potassiumD M Burley
Lancet (London, England)|August 18, 1979
Identifying the medical consultants of pharmaceutical companiesD M Burley
Journal of Clinical and Hospital Pharmacy|March 1, 1982
Therapeutic progress--Review III. Can drugs prevent recurrent myocardial infarction?D M Burley
Lancet (London, England)|April 2, 1983
Butter advertisingD M Burley
Lancet (London, England)|April 5, 1986
Should a drug company employee edit a medical journal?D M Burley
Lancet (London, England)|May 1, 1971
Halogenated oxyquinoline derivativesD M Burley
Postgraduate Medical Journal|July 1, 1970
Aminoglutethimide: a "side-effect" turned to therapeutic advantageS W Hughss, D M Burley
Lancet (London, England)|May 29, 1976
Letter: Erroneous adverse reaction reportsD M Burley, T B Binns
Medecine & Chirurgie Digestives|May 8, 1976
Rifampicine and enzyme inductionM Davies, R Williams, D M Burley
British Medical Journal|January 15, 1972
Effect of rifampicin and isoniazid on liver functionS Lal, S N Singhal, D M Burley, et al.
Pageof 2